Rapamycin-Eluting Coronary Cobalt Chromium Stent System
Is a new generation of Firebird rapamycin eluting stent.
Firebird 2 has a cobalt based metallic platform, a brand new bracket structure and a better biocompatibility, with a 2-layer biologically inertia styrene-butylenes-styrene (SBS) polymer coating.
34% increase in flexibility
15% increase in supporting strength
Better fatigue and corrosion resistant performance than stainless steel
Over 80% drug released out in one month
Late lumen loss is low to 0.05 in-stent, binary restenosis rate is 1.3% (in-segment), and volume obstruction is extremely low to 1.26% at 6 months.